158 related articles for article (PubMed ID: 38253368)
1. Unrestricted public coverage is needed for smoking cessation pharmacotherapies.
Kleinman RA; Selby P
CMAJ; 2024 Jan; 196(2):E53-E55. PubMed ID: 38253368
[No Abstract] [Full Text] [Related]
2. [Comparison of insurance coverage of tobacco cessation pharmacotherapies in five countries from the Organisation for Economic Co-operation and Development].
Le Faou AL; Scemama O
Rev Epidemiol Sante Publique; 2005 Nov; 53(5):535-48. PubMed ID: 16434927
[TBL] [Abstract][Full Text] [Related]
3. Medicaid reimbursement for prenatal smoking intervention influences quitting and cessation.
Petersen R; Garrett JM; Melvin CL; Hartmann KE
Tob Control; 2006 Feb; 15(1):30-4. PubMed ID: 16436401
[TBL] [Abstract][Full Text] [Related]
4. Use of pharmacotherapies for smoking cessation: analysis of pregnant and postpartum Medicaid enrollees.
Jarlenski MP; Chisolm MS; Kachur S; Neale DM; Bennett WL
Am J Prev Med; 2015 May; 48(5):528-34. PubMed ID: 25891051
[TBL] [Abstract][Full Text] [Related]
5. Current and Emerging Pharmacotherapies for Cessation of Tobacco Smoking.
Gómez-Coronado N; Walker AJ; Berk M; Dodd S
Pharmacotherapy; 2018 Feb; 38(2):235-258. PubMed ID: 29250815
[TBL] [Abstract][Full Text] [Related]
6. Comparative Safety of Smoking Cessation Pharmacotherapies During a Government-Sponsored Reimbursement Program.
Carney G; Maclure M; Malfair S; Bassett K; Wright JM; Dormuth CR
Nicotine Tob Res; 2021 Jan; 23(2):302-309. PubMed ID: 32484873
[TBL] [Abstract][Full Text] [Related]
7. Health insurance coverage for smoking cessation services.
Schauffler HH; Parkinson MD
Health Educ Q; 1993; 20(2):185-206. PubMed ID: 8491632
[TBL] [Abstract][Full Text] [Related]
8. Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers.
Schuit E; Panagiotou OA; Munafò MR; Bennett DA; Bergen AW; David SP
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD011823. PubMed ID: 28884473
[TBL] [Abstract][Full Text] [Related]
9. Emerging pharmacotherapies for smoking cessation.
Garwood CL; Potts LA
Am J Health Syst Pharm; 2007 Aug; 64(16):1693-8. PubMed ID: 17687057
[TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapy for smoking cessation in schizophrenia: a systematic review.
Kozak K; George TP
Expert Opin Pharmacother; 2020 Apr; 21(5):581-590. PubMed ID: 32011186
[No Abstract] [Full Text] [Related]
11. Health-care providers' concern regarding smoking cessation pharmacotherapies during pregnancy: Calls to a teratology information service.
Lee ML; Tran DT; Welsh A; Kennedy D; Havard A
Drug Alcohol Rev; 2020 Mar; 39(3):223-231. PubMed ID: 31984591
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the effectiveness of smoking cessation in the management of COPD.
Temitayo Orisasami I; Ojo O
Br J Nurs; 2016 Jul; 25(14):786-91. PubMed ID: 27467642
[TBL] [Abstract][Full Text] [Related]
13. More than Smoke and Patches: The Quest for Pharmacotherapies to Treat Tobacco Use Disorder.
Moerke MJ; McMahon LR; Wilkerson JL
Pharmacol Rev; 2020 Apr; 72(2):527-557. PubMed ID: 32205338
[TBL] [Abstract][Full Text] [Related]
14. Pharmacotherapies to enhance smoking cessation during pregnancy.
Oncken CA; Kranzler HR
Drug Alcohol Rev; 2003 Jun; 22(2):191-202. PubMed ID: 12850906
[TBL] [Abstract][Full Text] [Related]
15. Coverage of smoking cessation treatment by union health and welfare funds.
Barbeau EM; Li YI; Sorensen G; Conlan KM; Youngstrom R; Emmons K
Am J Public Health; 2001 Sep; 91(9):1412-5. PubMed ID: 11527772
[TBL] [Abstract][Full Text] [Related]
16. Physician smoking-cessation actions: are they dependent on insurance coverage or on patients?
Solberg LI; Davidson G; Alesci NL; Boyle RG; Magnan S
Am J Prev Med; 2002 Oct; 23(3):160-5. PubMed ID: 12350447
[TBL] [Abstract][Full Text] [Related]
17. The effect of five smoking cessation pharmacotherapies on smoking cessation milestones.
Japuntich SJ; Piper ME; Leventhal AM; Bolt DM; Baker TB
J Consult Clin Psychol; 2011 Feb; 79(1):34-42. PubMed ID: 21261432
[TBL] [Abstract][Full Text] [Related]
18. Disparity in the use of smoking cessation pharmacotherapy among Medicaid and general population smokers.
Murphy JM; Mahoney MC; Hyland AJ; Higbee C; Cummings KM
J Public Health Manag Pract; 2005; 11(4):341-5. PubMed ID: 15958934
[TBL] [Abstract][Full Text] [Related]
19. A brief review of pharmacotherapies for smoking cessation.
Lam CY; Minnix JA; Robinson JD; Cinciripini PM
J Natl Compr Canc Netw; 2006 Jul; 4(6):583-9. PubMed ID: 16813725
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological interventions for promoting smoking cessation during pregnancy.
Coleman T; Chamberlain C; Davey MA; Cooper SE; Leonardi-Bee J
Cochrane Database Syst Rev; 2015 Dec; (12):CD010078. PubMed ID: 26690977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
